Home-based cardiac rehabilitation using a novel mobile health exercise regimen following transcatheter heart valve interventions (home run hitter) - among older adults, heart valve disease is common…
Active Project Grant Awarded Last action
- Award ID
- R01AG073633
- Recipient
-
Vanderbilt University Medical Center UEI GYLUH9UXHDX5
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,972,641
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date 88% complete
- Place of performance
- Forest Hills, TN 37215, USA
Award details come from USAspending.gov.
Description
Home-based cardiac rehabilitation using a novel mobile health exercise regimen following transcatheter heart valve interventions (home run hitter) - among older adults, heart valve disease is common and often requires treatment with valve repair or replacement. What used to require open heart surgery can now be done with less invasive transcatheter heart valve interventions (thvis), allowing for less morbidity and quicker recovery. However, despite the safety and procedural success of thvis, over one-half of patients are dead, have poor quality of life (QOL), and/or are hospitalized 1 year after a thvi. Cardiac rehabilitation (CR) effectively mitigates these poor outcomes in patients with cardiovascular disease, including those undergoing heart valve procedures. However, among medicare beneficiaries, only 25% of those undergoing a thvi participate in center-based CR (cbcr), which highlights a significant unmet clinical need. To address this need, our long-term goal is to develop a home- based CR (hbcr) program that extends the benefits of CR to more individuals after thvis. Our over-arching hypothesis is that a hbcr mobile health intervention that innovatively addresses key target health behaviors will reduce clinical events and improve physical activity, functional capacity, and QOL after thvis and that an interactive delivery and longer duration of the active intervention will produce greater benefits. We propose a multicenter randomized controlled trial enrolling 375 patients undergoing aortic or mitral thvis who do not intend to participate in cbcr; those who intend to pursue cbcr will be followed in a registry. Participants will be assigned to 3 groups: control (1) VS. A hbcr mobile health intervention with hands-off (2) VS. Interactive (3) delivery. The intervention addresses key target health behaviors and includes apple watch (to encourage physical activity and give reminders on healthy living) and an exercise prescription (to build strength/balance). The hands-off and interactive delivery groups receive the same intervention, except for a video call (every other week) with an exercise physiologist (interactive group only). Each intervention group (hands-off, interactive) will be randomized to 12-week VS. 24-week duration of the active intervention. The CO-primary endpoints are: (1) clinical events composite (death, rehospitalization, skilled nursing facility visits); and (2) average daily total activity counts. Key secondary endpoints: amount, intensity, consistency of physical activity; 6-minute walk distance; and QOL. We test whether the hbcr mobile health intervention (compared to control) reduces clinical events and improves physical activity, function capacity, and QOL after thvi (aim 1) and whether interactive VS. Hands-FF delivery (aim 2) or 24-week VS. 12-week active duration (aim 3) of the intervention yields greater benefits. We also explore mediators of clinical benefit and mechanisms of behavior change. With population aging, prevalence of heart valve disease and number of thvis are rapidly increasing. Overcoming disablement associated with severe valve disease requires more than simply fixing a valve; the potential of thvis to improve quantity and quality of life is unfulfilled without integrating CR. If successful, our approach will optimize value of care and patient outcomes with broad implications for other patient populations.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $474,271 | |
| Amendment | $564,125 | |
| Amendment | $675,092 | |
| Amendment | $753,928 | |
| Amendment | $753,928 | |
| Original award | $751,297 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| The Medical University Of South Carolina | $49,783 | |
| Yale Univ | $22,780 | |
| University Of Pittsburgh - Of The Commonwealth System Of Higher Education | -$25,701 | |
| Regents Of The University Of Michigan | -$7,740 | |
| Wake Forest University Health Sciences | -$8,800 | |
| Piedmont Healthcare, Inc. | -$8,030 | |
| Medical Center Of The Rockies | -$2,200 | |
| Ahs Hospital Corp. | -$6,200 | |
| The Medical University Of South Carolina | $68,938 | |
| Inova Health Care Services | -$23,513 | |
| Duke University | -$20,543 | |
| The Medical University Of South Carolina | $33,628 | |
| Duke University | $26,000 | |
| Wake Forest University Health Sciences | $27,203 | |
| Cleveland Clinic Lerner College Of Medicine Of Case Western Reserve University | $0 | |
| University Of Pittsburgh - Of The Commonwealth System Of Higher Education | $19,686 | |
| The Medical University Of South Carolina | $35,311 | |
| Yale New Haven Health Services Corporation | $29,396 | |
| Medical Center Of The Rockies | $16,885 | |
| Piedmont Healthcare, Inc. | $17,824 | |
| Inova Health Care Services | $25,763 |
Show all 21
Quick answers
Who received award R01AG073633?
R01AG073633 was awarded to Vanderbilt University Medical Center by National Institute on Aging (National Institutes of Health) on June 1, 2022.
How much is award R01AG073633 worth?
$3,972,641 has been obligated on R01AG073633.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award